Barclays’s MEDIVATION, INC. MDVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-132,100
Closed -$7.97M 7124
2016
Q2
$7.97M Buy
132,100
+116,700
+758% +$6.62M 0.01% 973
2016
Q1
$693K Sell
15,400
-86,300
-85% -$3.13M ﹤0.01% 2849
2015
Q4
$4.88M Sell
101,700
-95,300
-48% -$4.11M 0.01% 1338
2015
Q3
$8.27M Buy
197,000
+43,000
+28% +$2.13M 0.01% 1047
2015
Q2
$8.78M Buy
154,000
+27,600
+22% +$1.7M 0.01% 1120
2015
Q1
$8.15M Buy
126,400
+10,400
+9% +$596K 0.01% 1209
2014
Q4
$5.74M Sell
116,000
-103,600
-47% -$5.39M 0.01% 1581
2014
Q3
$10.8M Buy
219,600
+143,000
+187% +$6.08M 0.01% 1119
2014
Q2
$2.95M Sell
76,600
-327,000
-81% -$11M ﹤0.01% 2238
2014
Q1
$12.9M Buy
403,600
+263,600
+188% +$9.72M 0.01% 965
2013
Q4
$4.41M Sell
140,000
-51,800
-27% -$1.57M ﹤0.01% 1932
2013
Q3
$5.66M Buy
191,800
+146,600
+324% +$4.19M 0.01% 1582
2013
Q2
$1.11M Buy
+45,200
New +$1.14M ﹤0.01% 3232

Other funds holding MDVN

Barclays's MDVN Position: Q3 2016 in Review

Barclays sold out of MEDIVATION, INC. (MDVN) in Q3 2016, closing a stake of 198,801 shares — an estimated $12M sold.

Barclays first reported a position in MDVN in Q2 2013 and held it in 13 quarters. The position peaked at $12M in Q2 2016. 53 funds tracked by Wall St. Rank hold MDVN as of Q3 2016.

  • Barclays reported no remaining MEDIVATION, INC. position as of Q3 2016 after selling out during the quarter.
  • Barclays sold 198,801 MEDIVATION, INC. shares in Q3 2016, an estimated $12M.
  • Barclays first reported a position in MEDIVATION, INC. in Q2 2013 and held it in 13 quarters.
  • Barclays's MEDIVATION, INC. position peaked at $12M in Q2 2016.
  • 53 funds tracked by Wall St. Rank held MEDIVATION, INC. as of Q3 2016.

Based on Barclays's 13F filing for Q3 2016, filed 14 Nov 2016.